文献速递乳房整形与再造

加速康复外科(ERAS)联合布比卡因脂质体在乳房切除术后组织扩张器乳房再造中的应用

Enhanced Recovery After Surgery (ERAS) With Exparel in Tissue Expander-based Breast Reconstruction Following Mastectomy.
PubMed 文献 · Aesthet Surg J · 2024-01-01

本研究回顾性比较了2021年7月至2022年5月间接受乳房切除术后一期组织扩张器再造的患者,ERAS方案于2021年12月实施,ERAS组在胸神经阻滞1/2平面使用布比卡因脂质体。结果显示ERAS组术后住院时间显著缩短(1.7天 vs 1.1天,P=.0004),住院期间总吗啡当量显著降低(65.0 vs 26.2,P<.001),而恢复室疼痛评分无显著差异。

要点

  • ERAS方案联合布比卡因脂质体胸神经阻滞可缩短组织扩张器再造患者术后住院时间。
  • ERAS组住院期间总吗啡当量显著低于ERAS前组,恢复室疼痛评分无显著差异。
  • 研究为回顾性设计,样本来自单中心。

核心结论

  • 引入加速康复外科方案联合布比卡因脂质体胸神经阻滞1/2平面可降低乳房切除术后组织扩张器再造患者的术后阿片类药物消耗和住院时间。

研究设计与样本

  • 回顾性研究,纳入2021年7月至2022年5月间接受乳房切除术后一期组织扩张器再造的患者,比较ERAS前组与ERAS组,ERAS方案于2021年12月实施。

主要发现

  • 术后住院时间ERAS组较ERAS前组显著缩短(1.7天 vs 1.1天,P=.0004)。
  • 恢复室平均疼痛吗啡当量ERAS前组6.1 vs ERAS组7.1(P=.406),无显著差异。
  • 住院期间总吗啡当量ERAS组显著低于ERAS前组(65.0 vs 26.2,P<.001)。

关键数值与推荐

  • ERAS方案包括在胸神经阻滞1/2平面使用布比卡因脂质体。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Enhanced recovery after surgery (ERAS) pathways have been widely shown to yield positive outcomes, including in plastic surgery. Our group has previously validated ERAS in our deep inferior epigastric perforator flap breast reconstruction population. OBJECTIVES: We evaluated whether the ERAS protocol and addition of liposomal bupivacaine affected patient outcomes at the time of mastectomy and first-stage tissue expander reconstruction. METHODS: All patients treated between July 2021 and May 2022 were reviewed retrospectively. The ERAS protocol was implemented in December 2021. Two patient groups were compared: pre-ERAS and ERAS. The ERAS protocol included use of liposomal bupivacaine in the pectoralis nerve block 1/2 planes. Primary outcomes were observed with postoperative length of stay and hospital narcotic use. RESULTS: Eighty-one patients were analyzed in this cohort. The pre-ERAS group was composed of 41 patients, the ERAS group was composed of 83 patients. Postoperative length of stay was significantly reduced in the ERAS group (1.7 pre-ERAS vs 1.1 ERAS, P = .0004). When looking at morphine equivalents during the hospital stay, the degree of narcotics in the recovery room was relatively similar. Average PACU pain morphine equivalents were 6.1 pre-ERAS vs 7.1 ERAS (P = .406). However, total hospital morphine equivalents were significantly lower in the ERAS group (65.0 pre-ERAS vs 26.2 ERAS, P = <.001). CONCLUSIONS: The introduction of an enhanced recovery after surgery protocol with liposomal bupivacaine pectoralis 1/2 nerve blocks decreased postoperative opioid consumption and hospital length of stay in mastectomy patients undergoing tissue expander-based reconstruction.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Haddock NT, Cummins S, Lakatta AC, et al. Enhanced Recovery After Surgery (ERAS) With Exparel in Tissue Expander-based Breast Reconstruction Following Mastectomy. Aesthet Surg J. 2024. PMID: 39147381. doi:10.1093/asj/sjae003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。